Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients

David J. Sugarbaker, Raja M. Flores, Michael T. Jaklitsch et al. · Journal of Thoracic and Cardiovascular Surgery · 1999 · 986 citations · Full text

Medicine, Oncology, Surgery +15

A Proposed New International TNM Staging System for Malignant Pleural Mesothelioma

Valerie W. Rusch · CHEST Journal · 1995 · 610 citations

Medicine, Oncology, Pathology +13

A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma

Valerie W. Rusch, Kenneth E. Rosenzweig, Ennapadam Venkatraman et al. · Journal of Thoracic and Cardiovascular Surgery · 2001 · 494 citations · Full text

Medicine, Oncology, Surgery +14

Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.

R T Heelan, Valerie W. Rusch, Colin B. Begg et al. · American Journal of Roentgenology · 1999 · 292 citations

Medicine, Oncology, Surgery +17

Metabolic Imaging of Malignant Pleural Mesothelioma With Fluorodeoxyglucose Positron Emission Tomography

François Bénard, Daniel H. Sterman, Robin J. Smith et al. · CHEST Journal · 1998 · 257 citations · Full text

Medicine, Nuclear Medicine, Oncology +17